Snake venom drug tried in advanced cancer patients
Disease control
Not yet recruiting
This early-phase trial tests a protein from snake venom (crotoxin) given through a vein to people with advanced solid tumors. The main goal is to see if patients can safely tolerate higher doses without severe side effects. About 24 adults whose cancer has not responded to standa…
Phase: PHASE1 • Sponsor: Celtic Biotech Ltd • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC